Congratulations on your nuptial! Ultimately, it’s all about your loved ones and family in bigger scheme of things.
Thank you for a great post.
I also hold a very bullish view on Meso product lines. I am a great fan of the Meso Team on their world changing stem cell research. However, I believe MESO management is being swayed by ego. They and we the followers know we have far superior products to enhance the quality of life. There are management team members who have previously worked for FDA. And a layman like myself would assume they are super experts on FDA processes. If a company is progressing for an FDA application for their product an investment shareholder will assume the team has done their due diligence and simple variance analysis on FDA processes for approval vs product specs, safety and data.
If material discrepancies are found then one would further assume that as a management these discrepancies are remediated before the application is tabled or have prior evidence that exemptions will be considered.
One this occasion, MSB has failed the investors and shareholders were taken for a ride with flabbergasting sugarcoated announcements.
Unproof read.
- Forums
- ASX - By Stock
- MSB
- MSB to dispute FDA finding in Type A meeting
MSB to dispute FDA finding in Type A meeting, page-455
-
-
- There are more pages in this discussion • 563 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
0.000(0.00%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.15 | $2.025M | 1.729M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 31955 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 28063 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 13774 | 1.165 |
21 | 93138 | 1.160 |
16 | 96494 | 1.155 |
21 | 247391 | 1.150 |
8 | 146091 | 1.145 |
Price($) | Vol. | No. |
---|---|---|
1.170 | 35217 | 7 |
1.175 | 82384 | 11 |
1.180 | 88704 | 11 |
1.185 | 59954 | 6 |
1.190 | 70277 | 6 |
Last trade - 12.27pm 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online